In the present study, we addressed the question of whether miR‐140‐5p inhibition in rat hippocampus can be useful to target the main pathological processes of AD, namely, impaired cognitive function, neuroinflammation, hyperphosphorylation of tau in the brain, and defective brain insulin signaling. This evidence concerns the gene MAPT and Alzheimer disease.